Principal Investigator
David Baidal
Enrollment Status
Closed
Clinical Trial ID
Institutional Protocol #
20170502
Clinical Trial Summary
TN-18: CTLA4Ig (Abatacept) For Prevention of Abnormal Glucose Tolerance and Diabetes in Relatives At Risk for Type 1 Diabetes Mellitus
Phase
Phase II
Funding Agency/Sponsor
Other
Disease
Other